SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO.___)
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
| o | Definitive Proxy Statement | |
| o | Preliminary Proxy Statement | |
| o | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| þ | Definitive Additional Materials | |
| o | Soliciting Material Pursuant to §240.14a-12 |
Chad Therapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| þ | No fee required. | ||||
| o | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. | ||||
| (1) | Title of each class of securities to which transaction applies: |
||||
| (2) | Aggregate number of securities to which transaction applies: |
||||
| (3) | Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it
was determined): |
||||
| (4) | Proposed maximum aggregate value of transaction: |
||||
| (5) | Total fee paid: |
||||
| o | Fee paid previously with preliminary materials. | ||||
| o | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||||
| (1) | Amount Previously Paid: |
||||
| (2) | Form, Schedule or Registration Statement No.: |
||||
| (3) | Filing Party: |
||||
| (4) | Date Filed: |
||||
CHAD THERAPEUTICS, INC.
21622 Plummer Street
Chatsworth, California 91311
(818) 882 0883
Chatsworth, California 91311
(818) 882 0883
ANNUAL MEETING OF SHAREHOLDERS
October 25, 2006
Supplement to Proxy Statement
This Supplement contains information supplemental to the Proxy Statement disseminated on or about
September 25, 2006.
STOCK PRICE PERFORMANCE GRAPH
The graph below compares the cumulative total stockholder return on our common stock with the
cumulative total return for the Hemscott Index and the SIC industry class for surgical and medical
instruments, for the five-year period ended March 31, 2006. The graph assumes that $100 was
invested in our common stock and each of the indices on March 31, 2001, and dividends, if any, were
reinvested. We did not pay any dividends on our common stock during the five-year period ended
March 31, 2006. Stockholder returns over the past five years should not be considered indicative of
future stock prices or stockholder returns.
The broad market index chosen was the Hemscott Index. The Industry Index chosen was SIC code
3841,Surgical and Medical Instruments & Apparatus. The current composition of the index is as
follows:
ABIOMED INC
|
DIOMED HOLDINGS INC | NUVASIVE INC | ||
AKSYS LTD
|
ELECTRO OPTICAL SCIENCES | OCCULOGIX INC | ||
AMDL INC
|
ENDOLOGIX INC. | ORASURE TECHNOLOGIES INC | ||
ANGIODYNAMICS INC
|
ENPATH MEDICAL INC. | ORTHOVITA INC. | ||
ANTARES PHARMA INC.
|
EP MEDSYSTEMS INC. | OSTEOTECH INC. | ||
ARISTOTLE CORP.
|
EV3 INC. | POINT THERAPEUTICS INC. | ||
ARROW INTERNATIONAL INC
|
FOXHOLLOW TECH INC | RESMED INC. | ||
ATRICURE INC.
|
HAEMONETICS CORP. | RETRACTABLE TECHNOLOGIES | ||
ATRION CORPORATION
|
HEARUSA INC. | ROCHESTER MEDICAL CORP. | ||
BAXTER INTERNATIONAL INC
|
HEMOSENSE INC. | SONOSITE INC. | ||
BECTON, DICKINSON & CO.
|
I-FLOW CORP. | STEN CORP | ||
BIOJECT MEDICAL TECH
|
ICU MEDICAL INC. | STRATEGIC DIAGNOSTICS | ||
BOSTON SCIENTIFIC CORP.
|
IMPLANT SCIENCES CORP. | STRYKER CORP. | ||
BOVIE MEDICAL
|
INOVIO BIOMEDICAL CORP | SYBRON DENTAL SPCLTS. | ||
C.R. BARD INC
|
IV AX DIAGNOSTICS INC | THORATEC CORP. | ||
CABG MEDICAL INC
|
KENSEY NASH CORP. | UROPLASTY | ||
CARDIAC SCIENCE CORP.
|
KINETIC CONEPTS INC | UTAH MEDICAL PRODUCTS | ||
CARDICA INC.
|
KYPHON INC | VASCULAR SOLUTIONS INC. | ||
CARDIOTECH INTERNAT INC
|
MED-DESIGN CORP | VASOGEN INC. | ||
CAS MEDICAL SYSTEMS INC
|
MEDSOURCE TECHNOLOGIES | VENTANA MEDICAL SYSTEMS | ||
CHINA MEDICAL TECHNOLS
|
MEDWAVE INC | VITAL SIGNS INC. | ||
CONCEPTUS INC
|
MEMRY CORPORATION | VIVUS INC. | ||
CONOR MEDSYSTEMS INC
|
MERIT MEDICAL SYSTEMS | |||
CRYOCOR INC
|
MINRAD INTERNATIONAL INC. | |||
CYTORI THERAPEUTICS INC.
|
NEPHROS INC. | |||
DAXOR CORP
|
NEUROMETRIX INC | |||
DEXCOM INC.
|
NMT MEDICAL INC. |